Antibodies to HNFIP24 polypeptides
    81.
    发明授权
    Antibodies to HNFIP24 polypeptides 失效
    HNFIP24多肽的抗体

    公开(公告)号:US08106165B2

    公开(公告)日:2012-01-31

    申请号:US11745580

    申请日:2007-05-08

    IPC分类号: C07K16/26 C07K16/00 C12N5/12

    摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.

    摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的疾病,病症和/或病症的诊断和治疗方法。

    Antibodies against nogo receptor
    82.
    发明授权
    Antibodies against nogo receptor 有权
    针对nogo受体的抗体

    公开(公告)号:US07973139B2

    公开(公告)日:2011-07-05

    申请号:US11090847

    申请日:2005-03-25

    摘要: The present invention relates to antibodies and related molecules that specifically bind to the Nogo receptor (NogoR). Such antibodies have uses, for example, in the treatment of spinal cord injury, brain trauma, paralysis, degenerative nervous system diseases, and stroke. The invention also relates to nucleic acid molecules encoding anti-NogoR antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same.

    摘要翻译: 本发明涉及特异性结合Nogo受体(NogoR)的抗体和相关分子。 这样的抗体具有例如用于治疗脊髓损伤,脑损伤,麻痹,退行性神经系统疾病和中风的用途。 本发明还涉及编码抗NogoR抗体的核酸分子,含有这些核酸的载体和宿主细胞及其制备方法。

    Human G-Protein Chemokine Receptor (CCR5) HDGNR10
    84.
    发明申请
    Human G-Protein Chemokine Receptor (CCR5) HDGNR10 审中-公开
    人类G蛋白趋化因子受体(CCR5)HDGNR10

    公开(公告)号:US20110081360A1

    公开(公告)日:2011-04-07

    申请号:US12943722

    申请日:2010-11-10

    摘要: The present invention relates to a novel human protein called Human G-protein Chemokine Receptor (CCR5) HDGNR10, and isolated polynucleotides encoding this protein. The invention is also directed to human antibodies that bind Human G-protein Chemokine Receptor (CCR5) HDGNR10 and to polynucleotides encoding those antibodies. Also provided are vectors, host cells, antibodies, and recombinant methods for producing Human G-protein Chemokine Receptor (CCR5) HDGNR10 and human anti-Human G-protein Chemokine Receptor (CCR5) HDGNR10 antibodies. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to this novel human protein and these novel human antibodies.

    摘要翻译: 本发明涉及一种称为人G蛋白趋化因子受体(CCR5)HDGNR10的新型人类蛋白质,以及编码该蛋白质的分离的多核苷酸。 本发明还涉及结合人G蛋白趋化因子受体(CCR5)HDGNR10的人抗体和编码那些抗体的多核苷酸。 还提供了用于产生人G蛋白趋化因子受体(CCR5)HDGNR10和人抗人G蛋白趋化因子受体(CCR5)HDGNR10抗体的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与该新型人蛋白质和这些新型人抗体相关的疾病,病症和/或病症的诊断和治疗方法。

    HEMCM42 nucleic acids
    85.
    发明授权
    HEMCM42 nucleic acids 有权
    HEMCM42核酸

    公开(公告)号:US07906634B2

    公开(公告)日:2011-03-15

    申请号:US12324825

    申请日:2008-11-26

    IPC分类号: C07H21/04

    CPC分类号: C07K14/47 A61K38/00 C07K16/00

    摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.

    摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的病症的诊断和治疗方法。

    Antibodies to HWHGU54 polypeptides
    87.
    发明授权
    Antibodies to HWHGU54 polypeptides 有权
    HWHGU54多肽的抗体

    公开(公告)号:US07838636B1

    公开(公告)日:2010-11-23

    申请号:US11760578

    申请日:2007-06-08

    CPC分类号: C07K14/47

    摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.

    摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的疾病,病症和/或病症的诊断和治疗方法。

    B-LYMPHOCYTE STIMULATOR BINDING POLYPEPTIDES AND METHODS BASED THEREON
    88.
    发明申请
    B-LYMPHOCYTE STIMULATOR BINDING POLYPEPTIDES AND METHODS BASED THEREON 有权
    B-LYMPHOCYTE刺激物结合聚合物及其方法

    公开(公告)号:US20100144058A1

    公开(公告)日:2010-06-10

    申请号:US12701301

    申请日:2010-02-05

    摘要: Binding polypeptides that specifically bind B lymphocyte stimulator protein or B lymphocyte stimulator-like polypeptides can be used in methods of the invention for detecting, diagnosing, or prognosing a disease or disorder associated with aberrant B lymphocyte stimulator or B lymphocyte stimulator receptor expression or inappropriate function of B lymphocyte stimulator or B lymphocyte stimulator receptor, comprising B lymphocyte stimulator binding polypeptides or fragments or variants thereof, that specifically bind to B lymphocyte stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B lymphocyte stimulator or B lymphocyte stimulator receptor expression or inappropriate B lymphocyte stimulator function or B lymphocyte stimulator receptor function, comprising administering to an animal, preferably a human, an effective amount of one or more B lymphocyte stimulator binding polypeptides or fragments or variants thereof, that specifically bind to B lymphocyte stimulator.

    摘要翻译: 特异性结合B淋巴细胞刺激物蛋白或B淋巴细胞刺激物样多肽的结合多肽可用于本发明的用于检测,诊断或预测与异常B淋巴细胞刺激物或B淋巴细胞刺激受体表达或不适当功能相关的疾病或病症的方法 B淋巴细胞刺激剂或B淋巴细胞刺激物受体,其包含特异性结合B淋巴细胞刺激物的B淋巴细胞刺激物结合多肽或其片段或变体。 本发明还涉及用于预防,治疗或改善与异常B淋巴细胞刺激剂或B淋巴细胞刺激剂受体表达或不适当的B淋巴细胞刺激物功能或B淋巴细胞刺激因子受体功能相关的疾病或病症的方法和组合物,其包括向动物, 优选人,有效量的一种或多种B淋巴细胞刺激剂结合多肽或其片段或变体,其特异性结合B淋巴细胞刺激物。